国家自然科学基金“血管稳态与重构的调控机制”重大研究计划学术交流会顺利召开

2015-02-13 陈敬洲 朱元贵 江虎军 医学科学部 

国家自然科学基金“血管稳态与重构的调控机制”重大研究计划2014年度学术交流会于2015年1月18日至20日在江西南昌召开。国家自然科学基金委员会医学科学部孙瑞娟副主任主持开幕式,国家自然科学基金委员会医学科学部董尔丹常务副主任致辞并强调了重大研究计划的定位、总体目标、实施管理要求以及医学科学部重大研究计划的布局情况,希望项目负责人和指导专家组通过学术交流,不断聚焦关键科学问题,加强学科交叉,产生

国家自然科学基金“血管稳态与重构的调控机制”重大研究计划2014年度学术交流会于2015年1月18日至20日在江西南昌召开。国家自然科学基金委员会医学科学部孙瑞娟副主任主持开幕式,国家自然科学基金委员会医学科学部董尔丹常务副主任致辞并强调了重大研究计划的定位、总体目标、实施管理要求以及医学科学部重大研究计划的布局情况,希望项目负责人和指导专家组通过学术交流,不断聚焦关键科学问题,加强学科交叉,产生原创性成果,实现跨越发展。本重大研究计划指导专家组主持了随后的学术交流与讨论。“血管稳态与重构的调控机制”重大研究计划指导专家组成员及学术秘书、特邀专家、管理组成员及2013年度、2014年度获资助项目负责人共86人参加了本次会议

会上,2013年度获资助项目负责人报告了工作进展,2014年获资助的重点支持项目负责人结合具体研究工作和领域研究进展作了学术报告。截至目前,本重大研究计划资助项目已取得一些创新性成果,论文已在Science,Nature communications,JCI等权威杂志发表。此外,为推进该项目的研究进展,利用学科交叉的优势开展创新性研究,指导专家组特别邀请了从事影像学、生物信息学、表观遗传学、细胞生物学、免疫学及纳米科学等研究领域的专家在会上作特邀报告,为实施本重大研究计划提供了新的视角。会议期间,专家组及管理组就本重大研究计划可能的集成方向、学科交叉、项目执行及管理等方面的问题进行了专题讨论。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2032933, encodeId=4426203293341, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Fri Apr 10 10:17:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754970, encodeId=d3581e54970b8, content=<a href='/topic/show?id=ec5995e752e' target=_blank style='color:#2F92EE;'>#重大研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95775, encryptionId=ec5995e752e, topicName=重大研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4036811817, createdName=zz12341246, createdTime=Fri Jul 24 11:17:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646695, encodeId=770e1646695a7, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Wed May 06 04:17:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337961, encodeId=1e99133e961f7, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497601, encodeId=8d5e149e60191, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15377, encodeId=ebd1153e774, content=能, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Feb 13 15:05:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15376, encodeId=5400153e639, content=信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2e61611475, createdName=wll2015, createdTime=Fri Feb 13 13:24:00 CST 2015, time=2015-02-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2032933, encodeId=4426203293341, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Fri Apr 10 10:17:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754970, encodeId=d3581e54970b8, content=<a href='/topic/show?id=ec5995e752e' target=_blank style='color:#2F92EE;'>#重大研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95775, encryptionId=ec5995e752e, topicName=重大研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4036811817, createdName=zz12341246, createdTime=Fri Jul 24 11:17:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646695, encodeId=770e1646695a7, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Wed May 06 04:17:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337961, encodeId=1e99133e961f7, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497601, encodeId=8d5e149e60191, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15377, encodeId=ebd1153e774, content=能, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Feb 13 15:05:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15376, encodeId=5400153e639, content=信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2e61611475, createdName=wll2015, createdTime=Fri Feb 13 13:24:00 CST 2015, time=2015-02-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2032933, encodeId=4426203293341, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Fri Apr 10 10:17:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754970, encodeId=d3581e54970b8, content=<a href='/topic/show?id=ec5995e752e' target=_blank style='color:#2F92EE;'>#重大研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95775, encryptionId=ec5995e752e, topicName=重大研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4036811817, createdName=zz12341246, createdTime=Fri Jul 24 11:17:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646695, encodeId=770e1646695a7, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Wed May 06 04:17:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337961, encodeId=1e99133e961f7, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497601, encodeId=8d5e149e60191, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15377, encodeId=ebd1153e774, content=能, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Feb 13 15:05:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15376, encodeId=5400153e639, content=信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2e61611475, createdName=wll2015, createdTime=Fri Feb 13 13:24:00 CST 2015, time=2015-02-13, status=1, ipAttribution=)]
    2015-05-06 changfy
  4. [GetPortalCommentsPageByObjectIdResponse(id=2032933, encodeId=4426203293341, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Fri Apr 10 10:17:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754970, encodeId=d3581e54970b8, content=<a href='/topic/show?id=ec5995e752e' target=_blank style='color:#2F92EE;'>#重大研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95775, encryptionId=ec5995e752e, topicName=重大研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4036811817, createdName=zz12341246, createdTime=Fri Jul 24 11:17:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646695, encodeId=770e1646695a7, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Wed May 06 04:17:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337961, encodeId=1e99133e961f7, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497601, encodeId=8d5e149e60191, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15377, encodeId=ebd1153e774, content=能, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Feb 13 15:05:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15376, encodeId=5400153e639, content=信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2e61611475, createdName=wll2015, createdTime=Fri Feb 13 13:24:00 CST 2015, time=2015-02-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2032933, encodeId=4426203293341, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Fri Apr 10 10:17:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754970, encodeId=d3581e54970b8, content=<a href='/topic/show?id=ec5995e752e' target=_blank style='color:#2F92EE;'>#重大研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95775, encryptionId=ec5995e752e, topicName=重大研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4036811817, createdName=zz12341246, createdTime=Fri Jul 24 11:17:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646695, encodeId=770e1646695a7, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Wed May 06 04:17:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337961, encodeId=1e99133e961f7, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497601, encodeId=8d5e149e60191, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15377, encodeId=ebd1153e774, content=能, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Feb 13 15:05:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15376, encodeId=5400153e639, content=信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2e61611475, createdName=wll2015, createdTime=Fri Feb 13 13:24:00 CST 2015, time=2015-02-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2032933, encodeId=4426203293341, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Fri Apr 10 10:17:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754970, encodeId=d3581e54970b8, content=<a href='/topic/show?id=ec5995e752e' target=_blank style='color:#2F92EE;'>#重大研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95775, encryptionId=ec5995e752e, topicName=重大研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4036811817, createdName=zz12341246, createdTime=Fri Jul 24 11:17:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646695, encodeId=770e1646695a7, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Wed May 06 04:17:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337961, encodeId=1e99133e961f7, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497601, encodeId=8d5e149e60191, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15377, encodeId=ebd1153e774, content=能, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Feb 13 15:05:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15376, encodeId=5400153e639, content=信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2e61611475, createdName=wll2015, createdTime=Fri Feb 13 13:24:00 CST 2015, time=2015-02-13, status=1, ipAttribution=)]
    2015-02-13 MedSci客户端网友

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2032933, encodeId=4426203293341, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Fri Apr 10 10:17:00 CST 2015, time=2015-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754970, encodeId=d3581e54970b8, content=<a href='/topic/show?id=ec5995e752e' target=_blank style='color:#2F92EE;'>#重大研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95775, encryptionId=ec5995e752e, topicName=重大研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4036811817, createdName=zz12341246, createdTime=Fri Jul 24 11:17:00 CST 2015, time=2015-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646695, encodeId=770e1646695a7, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Wed May 06 04:17:00 CST 2015, time=2015-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337961, encodeId=1e99133e961f7, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497601, encodeId=8d5e149e60191, content=<a href='/topic/show?id=02599201364' target=_blank style='color:#2F92EE;'>#调控机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92013, encryptionId=02599201364, topicName=调控机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bce9348572, createdName=villahu, createdTime=Sun Feb 15 02:17:00 CST 2015, time=2015-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15377, encodeId=ebd1153e774, content=能, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Feb 13 15:05:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15376, encodeId=5400153e639, content=信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2e61611475, createdName=wll2015, createdTime=Fri Feb 13 13:24:00 CST 2015, time=2015-02-13, status=1, ipAttribution=)]
    2015-02-13 wll2015

    信息优质,分享到朋友圈后我的同事朋友们给了一连串的赞。给我双倍积分吧

    0

相关资讯

自噬对血管功能的影响及与相关疾病的关联研究进展

   自噬(autophagy)是细胞利用溶酶体降解自身受损的细胞器和大分子物质的过程,在稳定细胞内环境 中发挥着重要作用.研究发现,自噬影响血管功能,与血管疾病的病理生理进程密切相关.本文从自噬对血管功能的影响,与血管相关疾病(如动脉粥样硬化、腹主 动脉瘤、肺动脉高压、糖尿病血管并发症等)的关系及药物对血管壁细胞自噬的调控进行综述,希望从自噬的角度来了解血管的功

橄榄油或可减轻空气污染对血管内皮危害

补充橄榄油能保护心血管,避免健康人群因空气污染所致心血管内皮功能紊乱。内皮功能紊乱是心血管事件高危因素,可进展为动脉粥样硬化。这是美国环境保护署(EPA)生物学家、医学博士Haiyan Tong等近期一项研究得出的主要结论。Tong博士于2014年5月19日在美国胸科协会国际会议上展示了她的研究结果。5月22日Medscape网站对该研究结果进行了推荐。Tong博士和同事评估了橄榄油和鱼油是如何对

Neurology:血管危险因素、大动脉粥样硬化对脑白质高信号的影响研究

脑白质高信号(WMH)是脑小血管病(SVD)的重要表现,并很大程度上增加痴呆,卒中以及残疾的发生风险。尽管其对临床患者和整个社会有相当大的影响,但目前对SVD以及WMH的病因知之甚少。研究显示WMH与常见的血管性危险因素(VRFs)相关,如高血压,高脂血症,糖尿病,吸烟以及颈动脉狭窄等。既往观察性随机对照试验研究显示高血压与WMH的进展相关,控制血压可以延缓WMH的进展。然而在一项大型的随机对照试

SCAI 2014 :血管内介入后双抗治疗未改变主要不良事件

在2014心血管造影与介入学会年会(SCAI2014)上公布的一项研究显示,在经下肢血管途径的血管内介入后给予双重抗血小板治疗未能改变患者的主要不良事件。 Swagata Das等分析了XLPAD注册研究中2005-2013年间334例连续血管内介入病例,所有患者接受阿司匹林81-325mg/日,及氯吡格雷75mg/日、替格瑞洛90mg/日、普拉格雷10mg/日中的一种,拟服药至术后12个月。 D

科学家7天造出全新血管

科学家现在只需要几勺鲜血,七天就能长出一培养皿的血管,而且完全能够替代你身体里的血管。医生在搭桥手术中将人造血管成功移植给了三名儿童。如此这种快捷的手术方法的安全性和可行性已经得到验证,医学工作者都可以使用这种创新法治疗全世界约2500万患有血管疾病的病人。 三年前,移植生物学教授Suchitra Sumitran-Holgersson和外科医师Michael Olausson为

Nat Commun:肿瘤研究新工具---特异性标记血管新生

血管为全身器官和组织运送氧气和营养物质,对机体组织的生长、再生、伤口愈合、组织修复以及胎儿生长大有益处,但同时也会成为感染导致的炎症扩散、肿瘤细胞入侵和转移的渠道。在原有毛细血管或微静脉的基础上通过血管内皮细胞的增殖和迁移,从已存在的血管处以出芽的方式产生新的毛细血管的,这一过程被称为血管新生(Angiogenesis)。血管新生是机体发育生长中的一个重要过程,在促血管新生因子和抑血管新生因子